China Bioprocess Validation Market Size & Outlook
China bioprocess validation market, 2018-2030 (US$M)
Related Markets
China bioprocess validation market highlights
- The China bioprocess validation market generated a revenue of USD 26.8 million in 2023 and is expected to reach USD 61.2 million by 2030.
- The China market is expected to grow at a CAGR of 12.5% from 2024 to 2030.
- In terms of segment, bioprocess residuals testing was the largest revenue generating testing type in 2023.
- Extractables & Leachables Testing is the most lucrative testing type segment registering the fastest growth during the forecast period.
Bioprocess validation market data book summary
| Market revenue in 2023 | USD 26.8 million |
| Market revenue in 2030 | USD 61.2 million |
| Growth rate | 12.5% (CAGR from 2023 to 2030) |
| Largest segment | Bioprocess residuals testing |
| Fastest growing segment | Extractables & Leachables Testing |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Extractables & Leachables Testing, Bioprocess Residuals Testing, Viral Clearance Testing, Filtration & Fermentation Systems Testing |
| Key market players worldwide | Eurofins Scientific SE, Sartorius AG, Merck KGaA, Thermo Fisher Scientific Inc, Lonza Group Ltd, Danaher Corp, Charles River Laboratories International Inc, SGS AG, Labcorp Holdings Inc, Cobetter Filtration |
Other key industry trends
- In terms of revenue, China accounted for 5.8% of the global bioprocess validation market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China bioprocess validation market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 61.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Bioprocess Validation Market Scope
Bioprocess Validation Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China bioprocess validation market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bioprocess validation market will help companies and investors design strategic landscapes.
Bioprocess residuals testing was the largest segment with a revenue share of 29.1% in 2023. Horizon Databook has segmented the China bioprocess validation market based on extractables & leachables testing, bioprocess residuals testing, viral clearance testing, filtration & fermentation systems testing covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to China bioprocess validation market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China bioprocess validation market databook
-
Our clientele includes a mix of bioprocess validation market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China bioprocess validation market , including forecasts for subscribers. This country databook contains high-level insights into China bioprocess validation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China bioprocess validation market outlook size, by testing type, 2018-2030 (US$M)
China Bioprocess Validation Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
